Skip to main content
. 2022 Nov 23;15:6393–6407. doi: 10.2147/JIR.S388792

Figure 2.

Figure 2

ROC curve of GSII, CD4, CD8, CD19 lymphocyte count among total patients. (A and B) ≤60 and >60 in training cohort. (C and D) ≤60 and >60 in validation cohort.